CRBP Corbus Pharmaceuticals Holdings Inc.

$6.7 -4.29%

493,114 Shares Traded
752,847 Average Volume (last 30 days)

as of March 22, 2018 EST IEX Real-Time Price

Short Pain Metrics

Approximate Amount of Money Shorts Have Made on the Day: $2.38 million
If Intiated on the First, Shorts Have Realized a Year to Date Return of:15.72%
If Intiated One Month Ago, Shorts Have Realized a Return of:12.99%
If Initiated Five Days ago, Shorts Have Realized a Return of:5.63%
Peer Potential Short Squeezes Near Real Time Screener
*Please note the actual returns of shorts could be different as they started from different points

Daily Indicators

Daily Short Pain Indicator [i] - Always Use Fundamentals on EverythingNeutral
200 Day Moving Average Indicator Bearish
50 Day Moving Average Indicator Bearish
52 Week High/Low Indicator Neutral

Short Stats

Short Percent to Float 13.86%
Short Interest7.92 million
Float57.13 million
Short Ratio6.89
Market Cap$382.8 million
Market Maker ActivityDaily Short Volume


Corbus Pharmaceuticals (CRBP) Presents At 38th Annual Cowen And Company Healthcare Conference - Slideshow (SeekingAlpha)
Corbus Pharmaceuticals revenues up 26% in FY 2017 (SeekingAlpha)
Corbus Pharmaceuticals reports FY results (SeekingAlpha)
Which Marijuana ETF Is Best For You? (SeekingAlpha)
Marijuana Stocks That Could Outpace The Market In 2018 (SeekingAlpha)
Key events next week - healthcare (SeekingAlpha)
Corbus Buying Opportunity As Shares Fall With Biotech Sector On $25M Cystic Fibrosis Grant (SeekingAlpha)
Corbus Is A Buy, But Not For Cystic Fibrosis (SeekingAlpha)
Corbus Pharmaceuticals (CRBP) Corporate Presentation - Slideshow (SeekingAlpha)
Biotech Analysis Central Pharma News: Bellicum's Clinical Hold, Vical's Restructuring Move, Corbus' Push On Cystic Fibrosis (SeekingAlpha)

Smart Money Sentiment

Institutional Ownership (Top 15 Funds) 30.6%

Earnings Stats

PE Ratio -10.31
Dividend Yield 0%
Peer EarningsEarnings Calendar


200 Day Moving Average $6.99
50 Day Moving Average $7.55
52 Week High $9.96
52 Week Low $5.3

Data provided for free by IEX. Questions? Read the FAQ